Thursday, April 30, 2020
Regulatory Affairs Outsourcing Market to expand at a CAGR of 10.1% CAGR from 201
Regulatory Affairs Outsourcing Market to expand at a CAGR of 10.1% CAGR from 201: Regulatory Affairs Outsourcing Market to expand at a CAGR of 10.1% CAGR from 2017 to 2023 - TMR
North America Porcine Vaccine Market will Rise to US$ 926.2 Mn by 2024 - TMR
North America Porcine Vaccine Market will Rise to US$ 926.2 Mn by 2024 - TMR: North America Porcine Vaccine Market will Rise to US$ 926.2 Mn by 2024 - TMR
Medical Image Analysis Software Market to Reach US$ 5.0 Bn by 2026 – TMR
Medical Image Analysis Software Market to Reach US$ 5.0 Bn by 2026 – TMR: Medical Image Analysis Software Market to Reach US$ 5.0 Bn by 2026 – TMR
Antithrombin Market by Application, Dosage Form & Forecast - 2025
Antithrombin Market by Application, Dosage Form & Forecast - 2025: Antithrombin Market by Application, Dosage Form & Forecast - 2025
Microdermabrasion Devices Market to Reach US$ 228.0 Mn by 2026 - TMR
Microdermabrasion Devices Market to Reach US$ 228.0 Mn by 2026 - TMR: Microdermabrasion Devices Market to Reach US$ 228.0 Mn by 2026 - TMR
Hospital Asset Management Market to Expand at a 12.0% by 2026 - TMR
Hospital Asset Management Market to Expand at a 12.0% by 2026 - TMR: Hospital Asset Management Market to Expand at a 12.0% by 2026 - TMR
Veterinary Endoscopes Market Size, Share & Trend | Industry Analysis Report, 202
Veterinary Endoscopes Market Size, Share & Trend | Industry Analysis Report, 202: Veterinary Endoscopes Market Size, Share & Trend | Industry Analysis Report, 2025
Oligonucleotide Synthesis Market by Product, Application, End Users & Forecast -
Oligonucleotide Synthesis Market by Product, Application, End Users & Forecast -: Oligonucleotide Synthesis Market by Product, Application, End Users & Forecast - 2025 | Transparency Market Research
Surgical Drapes Market by Types, End user & Forecast - 2025
Surgical Drapes Market by Types, End user & Forecast - 2025: Surgical Drapes Market by Types, End user & Forecast - 2025
Cardiopulmonary Stress Testing Systems Market-Global Industry Analysis, Size, Sh
Cardiopulmonary Stress Testing Systems Market-Global Industry Analysis, Size, Sh: Cardiopulmonary Stress Testing Systems Market-Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Home Rehabilitation Products and Services Market Size, Share & Trends | Industry
Home Rehabilitation Products and Services Market Size, Share & Trends | Industry: Home Rehabilitation Products and Services Market Size, Share & Trends | Industry Analysis Report, 2026
Diagnostic Imaging Services Market by Imaging Modality and Application by 2027 -
Diagnostic Imaging Services Market by Imaging Modality and Application by 2027 -: Diagnostic Imaging Services Market by Imaging Modality and Application by 2027 - TMR
Orthobiologics Market to Reach US$ 7.9 Bn by 2026 - TMR
Orthobiologics Market to Reach US$ 7.9 Bn by 2026 - TMR: Orthobiologics Market to Reach US$ 7.9 Bn by 2026 - TMR
Antibacterial Drugs Market by Drug Class, Geography and Forecast to 2027 - TMR
Antibacterial Drugs Market by Drug Class, Geography and Forecast to 2027 - TMR: Antibacterial Drugs Market by Drug Class, Geography and Forecast to 2027 - TMR
Medical Waste Containers Market Size & Trends | Industry Analysis Report, 2026
Medical Waste Containers Market Size & Trends | Industry Analysis Report, 2026: Medical Waste Containers Market Size & Trends | Industry Analysis Report, 2026
Wednesday, April 29, 2020
Tuesday, April 28, 2020
Chromatography Syringes Market Latest News
Chromatography Syringes Market Latest News: Chromatography Syringes Market Latest News - SWOT Analysis of Major Industry Segments 2025
The global chromatography syringes market can be segmented in terms of chromatography, needle tip style, syringe type, material used, end-user, and region. In terms of chromatography, the market can be classified into gas chromatography, liquid chromatography, and thin-layer chromatography (TLC). Based on needle tip style, the global chromatography syringes market can be categorized into auto-sampler syringes, manual injection syringes, electronic injection syringes, side hole dome syringes, and plunger style syringes. In terms of syringe type, the market can be bifurcated into fixed needle syringes and removable needle syringes. In terms of material used, the global chromatography syringes market can be classified into metal syringes, polytetrafluoroethylene (PTFE) syringes, glass syringes, and others. Based on end-user, the market can be segmented into pharmaceutical & biotechnology companies, food & beverage companies, academic & research institutes, contract research organizations (CROs), contract manufacturing organizations (CMOs), biobanks, clinical laboratories, forensic centers, and pathology laboratories.
Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=35981
Giant Cell Arteritis Therapeutics Market Trends Will Generate New Growth Opportu
Giant Cell Arteritis Therapeutics Market Trends Will Generate New Growth Opportu: Giant Cell Arteritis Therapeutics Market Trends Will Generate New Growth Opportunities in Upcoming Year\
Global Giant Cell Arteritis Therapeutics Market: Introduction
- Giant cell arteritis (GCA) is a form of vasculitis, a family of rare disorders, which is characterized by inflammation of the blood vessels that can restrict flow of blood and damage vital organs and tissues. GCA is also called temporal arteritis and it generally affects the arteries in the scalp and neck, especially the temples. It can also affect the aorta and its large branches to the head, arms, and legs. GCA is the most common form of vasculitis in adults aged over 50.
- The most common symptoms of giant cell arteritis include throbbing headaches, fever, jaw pain, vision problems, and joint pain. Early treatment is vital to prevent serious complications such as stroke or blindness.
Key Drivers of Global Giant Cell Arteritis Therapeutics Market
- Rise in prevalence of cardiovascular disorders across the world boosts the growth of the global giant cell arteritis therapeutics market. Heart disease is the leading cause of death among men, women, and people of racial and ethnic groups in the U.S. One person dies every 37 seconds in the country from cardiovascular disease.
- Increase in the geriatric population is also one of the major drivers of the global giant cell arteritis therapeutics market. According to the WHO, the proportion of the world's population over 60 years will double from about 11% in 2000 to 22% in 2050. The absolute number of people aged 60 years and above is expected to increase from 605 million to 2 billion during the same period.
- Rise in awareness and technological advancements in health care are encouraging people to opt for advanced and modern treatment procedures for treating giant cell arteritis. This is projected to fuel the growth of the global giant cell arteritis treatment market.
Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Giant Cell Arteritis Therapeutics Market Report
Carbuncle Treatment MarketForecast Prospects and Growth Assessment
Carbuncle Treatment MarketForecast Prospects and Growth Assessment: Carbuncle Treatment MarketForecast Prospects and Growth Assessment
Carbuncle Treatment Market: Introduction
- Carbuncle is a bacterial infection that infects the hair follicles on skin. It is primarily caused by bacteria Staphylococcus aureus. Scrapes, broken skin, and moist parts of the body are the favorable conditions for carbuncle infection.
- Carbuncle usually develops on the back of the neck, shoulders, on thighs, armpits, buttocks, and any part of the body that tends to sweat. It causes red, painful, and swollen skin at the site of infection. It can spread up to 2 inches to 5 inches long and is more likely to leave a scar.
- People with diabetes, dermatitis, kidney & liver diseases, and patients with poor immune system are more susceptible to carbuncle
- Treatment of carbuncle depends on various factors such as size, location, and the duration for which the infection was left untreated
- Carbuncle can be treated with home remedies, antibiotics, pain relievers, and antibacterial soaps. In severe cases, surgery is advised if carbuncle does not respond to medical treatments.
Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Carbuncle Treatment Market Report
Herbal Analgesics Market Trends Size, Share, Trend and Industry Analysis Report
Herbal Analgesics Market Trends Size, Share, Trend and Industry Analysis Report: Herbal Analgesics Market Trends Size, Share, Trend and Industry Analysis Report
Herbal Analgesics Market: Introduction
- Painkillers or analgesics are used to treat pain and aches. External and internal analgesics are used to relieve pain resulting from cancer treatment, phantom aches, inflammation, neuropathic conditions, surgeries, wounds, etc.
- Natural products play a key role in the discovery of analgesic drugs, as these help to define tedious mechanisms involved in messenger transmission and pain relief. Recently, a number of substances with antionociceptive actions have been redefined from natural sources, which possess unique structural classes and show more understanding of pharmacological mechanism of actions.
- Currently, demand for herbal products is high, as these have no/less side effects and no addictive potential. For example, presently, 40% to 45% of all medicines in the drug industry are derived indirectly or directly from natural sources. The WHO research findings suggest that nearly 25% are derived from plants, 15% from microorganisms, and 3% to 5% from animals. Capsaicin, morphine, quinine, captopril, and digitalis are some of the examples of drugs manufactured from natural sources.
Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Herbal Analgesics Market Report
Interspinous Process Decompression Devices MarketForecast Key Manufacturers, Dev
Interspinous Process Decompression Devices MarketForecast Key Manufacturers, Dev: Interspinous Process Decompression Devices MarketForecast Key Manufacturers, Development Trends and Competitive Analysis
Interspinous Process Decompression Devices Market: Introduction
- Interspinous process decompression devices are also known as interspinous spacers. Interspinous process decompression is a minimally invasive procedure which utilizes a stand-alone spacer that serves as a joint extension blocker, for relieving neural compression in patients with spinal stenosis.
- Interspinous spacers can be defined as medical devices that are implanted in the lower spine to relieve painful symptoms of spinal stenosis, which is caused due to narrowing of spinal canal. Lumbar spinal stenosis is thinning of the spinal canal in the lower back, which causes compression of nerves. The condition develops gradually with age.
- Spacers are placed between two interspinous processes in the lower spine through minimally invasive procedures. Interspinous spacers are implanted between those vertebrae in such a way that they prevent patients from bending too far backward. The procedure is simple, and sometimes patient can go home within a day.
Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Interspinous Process Decompression Devices Market Report
Vitamin Deficiency Treatment Market Trends Shares, Strategies, and Forecasts Ana
Vitamin Deficiency Treatment Market Trends Shares, Strategies, and Forecasts Ana: Vitamin Deficiency Treatment Market Trends Shares, Strategies, and Forecasts Analysis
Growing Prevalence of Vitamin Deficiency Cases Worldwide to Propel Market Growth
The healthcare sector is continually finding new ways to address the burdening problems associated with vitamin deficiencies. As the number of individuals suffering from vitamin deficiencies continues to grow at an exponential rate worldwide, vitamin deficiency treatments have gained a great amount of attention over the past couple of decades. Some of the major factors that are expected to influence the expansion of the vitamin deficiency treatment market during the forecast period include rising prevalence of acute and chronic disorders, surge in the number of research & development activities, and growing demand for vitamin D and vitamin B complex, owing to the health benefits.
At present, a great number of research activities are focusing on addressing health issues and risks involved with nutritional deficiencies. Vitamin D testing and treatment has witnessed considerable growth in the past few years. Guidelines pertaining to the treatment of various vitamin deficiencies continue to evolve due to research. As vitamin D deficiency continues to emerge as a global burden, apart from vitamin deficiency treatment, tackling vitamin D deficiency would require robust public health actions, including vitamin D food fortification. At the back of these factors, the global vitamin deficiency treatment market is expected to reach a value of ~US$ 9.5 Bn by the end of 2027.
To know the scope of our report Get a Sample on Vitamin Deficiency Treatment Market
Pyrogen Testing Market Analysis: Business Overview and Global Development Trends
Pyrogen Testing Market Analysis: Business Overview and Global Development Trends: Pyrogen Testing Market Analysis: Business Overview and Global Development Trends
Introduction of Pyrogen Test in Different Applications: Key Driver
- Pyrogen testing is widely used across a number of healthcare arenas including pharmaceuticals, biotechnology and medical device companies. Introduction of pyrogen testing for pharmaceutical products such as products such as medicines, drugs, and immunological products lead to numerous advantages to the industry including product safety, efficiency and proper utilization of resources
- Pyrogen testing plays an important role in detecting endotoxins & other pathogens and enable to maintain quality of healthcare services in various healthcare settings
- According to the FDA, The Center for Devices and Radiological Health (CDRH) adopted the USP Endotoxin Reference Standard
Increase in New Innovative Drugs & Launch of Biologics Products Boost Market Growth
- Extensive research in and launch of new biologics is likely to speed up the growth of pyrogen testing market during the forecast period
- Launch of new drugs, significant growth of pharmaceutical industry and increase in emphasis expenditure for new product development enables to determine the growth of pyrogen testing market in future
Get a glimpse of the in-depth analysis through our Report Brochure
Renal Biomarkers Market Trends Trends and Growth Factors Analysis
Renal Biomarkers Market Trends Trends and Growth Factors Analysis: Renal Biomarkers Market Trends Trends and Growth Factors Analysis
Biomarker is a measurable biological indicator of the health status of an individual, especially of one at the risk of developing or presence of a particular disease. In the past, the term ‘biomarker’ referred to physiological traits, however, with the advent of technologically advanced diagnostic measures, biomarkers now refer to products of metobolomic, genomic, and proteomic research. Chronic kidney disease (CKD) is a major risk multiplier for cardiovascular disease, diabetes, hypertension, inflammatory disease of kidney (glomerulonephritis), and aging. World Kidney Day, a global awareness campaign, estimated that 10% of the global population is affected by chronic kidney disease.
According to the Centers for Disease Control and Prevention (CDC), more than 26 million Americans are affected by chronic kidney disease. Chronic kidney disease leads to end-stage renal disease (ESRD), if not treated. It was estimated by the National Kidney Foundation in 2015 that about 468,000 ESRD affected patients were on dialysis in the U.S.
Acute kidney injury (AKI) is a more severe renal condition, which if left untreated, poses a high risk of death. Traditional methods of diagnosing kidney diseases, such as serum creatinine and blood urea nitrogen levels, lack in sensitivity and specificity and are time consuming. With the development of genomics, proteomics, transcriptomics, and metabolomics, introduction of novel diagnostic techniques, such as renal biomarkers, are expected to help in timely detection of renal diseases. Rapidly increasing incidence of cardiovascular diseases and diabetes propel the global renal biomarkers market.
In 2014, data from the CDC indicated that approximately 26.7 million or 11.5% of the U.S. adults were diagnosed with heart diseases, which is likely to rise further due to increase in incidence of advanced kidney diseases and complications. In addition, factors such as alcohol and tobacco consumption, obesity, and genetic as well as hereditary factors lead to growth in the number of patients suffering from kidney diseases. Rise in patient pool is projected to boost the demand for diagnostic tests with greater efficacy, such as, renal biomarkers.
Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49386
Healthcare Supply Chain Management Market Growth - Major Factors Driving the Ind
Healthcare Supply Chain Management Market Growth - Major Factors Driving the Ind: Healthcare Supply Chain Management Market Growth - Major Factors Driving the Industry 2026
Global Healthcare Supply Chain Management Market: Overview
The global healthcare supply chain management market is expected to expand owing to the increasing pressure faced by healthcare providers to improve operational efficiency. Further the emergence of cloud-based solutions, adoption of the GS1 system and growing focus to curb the large-scale counterfeiting of drugs in the pharmaceutical industry are the primary booster of the global healthcare supply chain management market. Healthcare supply chain management aims to increase operational efficiency and traceability of the entire process of supply chain with the help of several software and tools.
An upcoming report by Transparency Market Research on the global medical device complaint management market would help readers understand crucial aspects of the market. It will offer an in-depth analysis of future prospects of global medical device complaint management market. The compilation will offer qualitative and quantitative assessment of the market. To add value to the report analysis TMR analysts has added latest trend, key drives, restrains, opportunity and challenges of the global medical device complaint management market. In addition to this, a thorough analysis on geographical segmentation and competitive landscape will help reader have a better understanding of the global medical device complaint management market.
Global Healthcare Supply Chain Management Market: Trends and Opportunities
The healthcare supply chain management solutions market is growing owing to the significant benefit offered by these software to various stakeholders. Some of consumers of supply chain management software are healthcare providers, distributors, and suppliers. Apart from this, global stakeholders are focusing to reduce their operating costs. These software are one way by which they can achieving operational efficiency. Some of the other perks of adopting healthcare supply chain management solutions are increased business intelligence, seamless business process and efficient management.
Despite of several drivers, high costs associated with the implementation and maintenance of these utilities are expected to restrict the growth. Due to this, small to medium-sized hospitals and pharmacies find it difficult to adopt in their infrastructure. However, increasing awareness of the benefits offered by the healthcare supply chain management applicants are expected to hold lucrative avenues for the growth of the market.
Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62058
Polymer Implantables Market Latest News - Brief Analysis by Top Key Players
Polymer Implantables Market Latest News - Brief Analysis by Top Key Players: Polymer Implantables Market Latest News - Brief Analysis by Top Key Players
Implantables, commonly known as prosthetics, are medical devices which are used to replace missing or abnormal body parts or organs. Various biomaterials are used for the development of implants such as metals, polymers, ceramics, and composites. The choice of material for implant development depends on application area, duration of implantation, biochemical properties of the material, and the material’s impact on tissues in the vicinity. Polymers have been used in the development of implants as these offer biocompatibility, tissue regeneration, flexibility, and strength. Polymers are widely used in orthopedic, esthetic, and cardiovascular implants beside which they are also been considered in implantable drug delivery devices for target specific drug delivery for the treatment of cancer and other disease indications.
Polymers are used in the development of orthopedic implants such as spine implants, spinal spacers and discs, joint replacement implants, tendons, and ligaments. Increasing geriatric population is estimated to drive the demand for polymer-based orthopedic implants. It is estimated that more than 50% of orthopedic implants are used in patients aged 65 years and above. Moreover, with increasing demand for esthetics, the consumption of esthetic implants such as silicone-based breast implants and maxillofacial implants is projected to grow. Polymers are also used in cardiovascular implants such as drug eluting stents and artificial heart valves. According to an independent study conducted in the U.S., about 75% of coronary stents deployed in the U.S. was polymer-based drug eluting stents. Increase in the prevalence of cardiovascular diseases is expected to drive the growth of the polymer implantables market during the forecast period. However, there have been few adverse events in the recent years regarding the esthetic implants made with silicone, which has hampered the market growth. Additionally, inappropriate selection of materials, low-quality raw materials, and high cost of implants are the concerned areas of the polymer implantables market, which are estimated to restrain the market growth during the forecast period.
Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30479
Recombinant Coagulation Factors Market Forecast Development, Trends, Segmentatio
Recombinant Coagulation Factors Market Forecast Development, Trends, Segmentatio: Recombinant Coagulation Factors Market Forecast Development, Trends, Segmentations Analysis
The advancement in technology that has endorsed manufacturing of recombinant proteins on a large scale industrial production for development of hemophilia and thrombosis treatments. Recombinant coagulation factors, as opposed to plasma-derived counterparts, consume a very low risk for transfer of infectious diseases and their use would eliminate the risk of infection from viruses such as the human immunodeficiency virus and hepatitis C. The advancement of recombinant coagulation factors has been a major importance in hemophilia care promising nearly complete safety of individuals from the risk of transmitted infections.
Rising number of hemophilia patients across the world, growing prophylactic treatment, and increasing demand for diagnosis rates for prevention of bleeding are likely to fuel the growth of recombinant coagulation factors market. In addition, increasing research and development activities on recombinant factor VIII is projected to boost the growth of the recombinant coagulation factors market. However, high cost treatment of hemophilia care and low cost treatment from plasma coagulation factor available alternatives to recombinant coagulation factors are obstructing the growth of recombinant coagulation factors market. While the R&D pipeline of recombinant coagulation factors is growing, other methods are strongly developing in early clinical development which may become the real threat to the recombinant coagulation factors market.
The recombinant coagulation factors market can be segmented based on type, hemophilia type, end-user, and region. In terms of type, the market can be categorized into recombinant factor VIII, recombinant factor IXa, recombinant factor VIIa, and Von Willebrand factor. Recombinant factor VIIa or (rFVIIa) is available for treatment of people suffering from hemophilia with inhibitors who experience bleeding or require surgery. Recombinant or human plasma-derived factor IX products are used in the treatment and prevention of bleeding in patients with hemophilia B. Wide acceptance of recombinant coagulation factors throughout the developed world has considerably increased the supply of coagulation factor that concentrates and helped development of aggressive therapeutic interferences such as prophylaxis.
Based on hemophilia type, the global recombinant coagulation factors market can be segmented into hemophilia A and hemophilia B. Hemophilia A (factor VIII deficiency) results from a missing or deficient protein needed for blood clotting. People suffering from hemophilia B bleed longer than other people. Hemorrhages can occur externally, from dental procedures, minor cuts, or trauma or internally in joints and muscles. In terms of end-user, the market can be segmented into research organizations, hospitals, clinics, and academic institutes.
Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30542
The global recombinant coagulation factors market can be segmented into five major regions: North Ame
Carotid Ultrasound Imaging Market Latest News Segments, Leading Player, Applicat
Carotid Ultrasound Imaging Market Latest News Segments, Leading Player, Applicat: Carotid Ultrasound Imaging Market Latest News Segments, Leading Player, Application & Forecast Analysis
Carotid ultrasound, also known as carotid duplex ultrasonography (CUS), is an imaging and diagnostic technique for assessment and diagnosis of carotid artery diseases. Carotid artery diseases are characterized by blockage of carotid arteries due to accumulation of fat, cholesterol, and other substances which often results in stenosis of carotid arteries, leading to stroke and other cardiovascular diseases. The carotid ultrasound technology uses sound waves to produce images of carotid arteries which enables health care providers to diagnose any blockage of arteries by analyzing the macroscopic appearances of fat depositions and flow characteristics. Carotid duplex ultrasonography (CUS) is a highly reliable diagnostic imaging technique and is well accepted by patients suffering from the fear of closed spaces, especially during magnetic resonance imaging (MRI). Carotid ultrasound imaging has no radiation risks to patients and is safer than conventional angiography technique. Various clinical trials conducted across the world, including the North American Symptomatic Carotid Endarterectomy Trial and Asymptomatic Carotid Artery Stenosis Trial, have successfully demonstrated the effectiveness of the carotid ultrasound imaging technique. Various health care organizations have established guidelines and best clinical practices for health care providers across the world for the use of carotid ultrasound imaging technique.
Increase in incidence of cardiovascular diseases such as stroke, myocardial infraction, and other disorders; technological advances in the ultrasound imaging equipment and techniques; growing adoption of the carotid ultrasound imaging technique among health care providers across the world, rise in awareness among general population regarding early diagnosis, and ongoing clinical trials leading to new application areas for the imaging and diagnostic techniques are expected to drive the global carotid ultrasound imaging market during the forecast period. However, lack of uniformity in reimbursement policies regarding the use of the technique in several countries is expected to restrain the market during the forecast period.
Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=31577
Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry Overv
Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry Overv: Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry Overview and Forecast Analysis
Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry OvervBronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period. The global bronchopulmonary dysplasia treatment market can be segmented based on drug type, therapy, end-user, and region. In terms of drug type, the market can be divided into bronchodilators, corticosteroids, diuretics, immunomodulators, and others. Based on therapy, the global bronchopulmonary dysplasia treatment market can be categorized into oxygen therapy, surfactant replacement therapy, mechanical ventilation, and others. The oxygen therapy segment is expected to hold a significant share of the global market during the forecast period due to factors such as effectiveness of drugs and more commonly used therapy. Based on end-user, the global bronchopulmonary dysplasia treatment market can be classified into hospitals, nursing homes, critical care units, and others. Request the Coronavirus Impact Analysis across Industries and Markets @ https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=33566 |
Monday, April 27, 2020
Acute Agitation and Aggression Treatment Market: Technological Growth Map over T
Acute Agitation and Aggression Treatment Market: Technological Growth Map over T
Acute Agitation and Aggression Treatment Market - Profitability Lies in the Exclusiveness of Product Portfolio
The number of people suffering from dementia, as found by the World Health Organization (WHO), is estimated to reach 70 million by 2030, and exceed 105 million by 2050. The prevalence of mental health disorders and their progression at a staggering rate is being well-analyzed by government authorities and discerning investors across the world, which is leading to huge investments in the acute agitation and aggression treatment landscape.
With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas. In 2018, the acute agitation and aggression treatment market registered a value of ~US$ 2.9 billion, and is projected to represent a compound annual growth rate of ~5 percent during 2019-2027 - finds a recently published Transparency Market Research (TMR) report.
Modern-day individuals give equal attention to mental health and physical health, given the easy access to healthcare information through online and offline channels. Intense research & development activities undertaken for the introduction of novel drugs with high efficiency and potency, coupled with numerous pipeline drugs, are projected to add new growth tangents to the acute agitation and aggression treatment market.
Looking for Customized Insights to build your business for future, ask for a sample report here
Pseudomonas Aeruginosa Infection Treatment Market Will Generate New Growth Oppor
Pseudomonas Aeruginosa Infection Treatment Market Will Generate New Growth Oppor
Pseudomonas Aeruginosa Infection Treatment Market – Vast Scope of Novel Treatment Approach Shows Way for Growth
The appearance of drug-resistant strains of pseudomonas aeruginosa, leading to high mortality rates, have led to a large number of new approaches for the treatment of the associated infection. So much so, infections due to pseudomonas aeruginosa are now considered a public health concern. Meanwhile, increasing antibacterial drug resistance has necessitated research and innovations in the antibacterial field, in general. According to statistics of the Centers for Disease Control and Prevention, in the U.S., each year, more than 2 million infections and 23,000 deaths are associated with bacterial drug resistance.
To address this issue, enormous research and innovation efforts are underway in the antibacterial field. In particular, for pseudomonas aeruginosa, the development of anti-infectives, new antibiotic formulations, and the antivirulence approach are some of the initiatives taken for the fight against the pathogen. Such needs have risen due to real concerns of hospital-acquired infections associated with pseudomonas aeruginosa, especially among critically-ill and immunocompromised patients.
This has prompted several studies to evaluate the factors for the drug resistance of pseudomonas aeruginosa, and potential consequences on mortality. Besides this, limitations of current therapies, potential for alternative drugs, and new therapeutic options for pseudomonas aeruginosa bode well for the pseudomonas aeruginosa treatment infection market. Transparency Market Research (TMR) has released a market study publication on the pseudomonas aeruginosa treatment infection market. According to the findings of TMR, the pseudomonas aeruginosa treatment infection market is predicted to expand at a notable ~6% CAGR over the forecast period of 2019 to 2027.
However, on the downside, the development of pseudomonas aeruginosa infection treatment faces hindrances as well. Firstly, scientific and technical challenges pertaining to the development of new antibacterial drugs is impeding pharma companies in such pursuits. Besides, the high cost of development of novel antibacterial formulations that are mostly kept in reserve, makes it difficult for companies to recover their investments. Incidence of incorrectly prescribed antibacterial drugs resulting in the rise of resistant bacteria is a bottleneck for the development of pseudomonas aeruginosa infection treatment options.
Identify the key factors that will drive your company’s growth. Request a brochure of this report here
von Willebrand Disease Treatment Market Prospects and Growth Assessment
von Willebrand Disease Treatment Market Prospects and Growth Assessment
Global Von Willebrand Disease Treatment Market: Continued Research Regarding Rare Bleeding Disorders to Offer Growth Prospects for Competitors
Continued rise in the prevalence of bleeding disorders has stirred key developments in the healthcare sector, in an attempt to manage these disorders. Despite the global prevalence of bleeding disorders, awareness of these conditions and their management has been insignificant. Healthcare professionals often have lesser diagnostic and treatment skills with incomplete access to diagnostic modalities essential for accurate recognition. von Willebrand disease is one such hereditary bleeding disorder associated with the qualitative and quantitative defect of the von Willebrand factor. On account of the growing incidences of this disease, von Willebrand disease treatment remains pivotal for healthcare professionals.
Transparency Market Research (TMR), in its recently published report on the von Willebrand disease treatment market, uncovers key aspects pertaining to the industry, showcasing developments in the market. Continued efforts towards battling the disease prevalent among geriatric patients and increasing government initiatives for the development of orphan drugs, coupled with continued technological advancements that enable new drug development are likely to drive the growth of the von Willebrand disease treatment market.
Planning to lay down future strategy? Perfect your plan with our report brochure here
Pigmentation Disorders Treatment Market Trends: Technological Growth Map over T
Pigmentation Disorders Treatment Market Trends: Technological Growth Map over T
Global Pigmentation Disorders Treatment Market - Snapshot
Pigmentation disorders include a large number of heterogeneous conditions that are usually characterized by altered melanocyte density, melanin concentration, or both, and result in altered pigmentation of the skin. Pigmentation disorders are of three types: hypopigmentation, depigmentation, or hyperpigmentation. Areas where pigmentation appears may be focal or diffuse. In hypopigmentation, pigments are decreased, whereas in depigmentation, pigments are completely lost, leaving the skin white. The most common disorders are melasma (hyperpigmentary) and vitiligo (hypopigmentary). The global pigmentation disorders treatment market was valued at around US$ 5,225 Mn in 2017 and is anticipated to expand at a CAGR of more than 6.8% from 2018 to 2026 to reach around US$ 9,268.6 Mn in 2026. Several factors such as augmented adoption of lasers in pigmentation disorders treatment, decrease in social taboos boosting acceptance of pigmentation disorders treatment measures, and increase in prevalence of pigmentation-related disorders are driving the global pigmentation disorders treatment market.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34418
After stringent restructuring of regulations against dermo-cosmetic products and services, companies have started focussing on efficacy and quality with high investments in R&D. This has ultimately helped boost technological development and emergence of new products, services, and devices in the pigmentation disorder treatment market. The products and services have been moderated by regulatory bodies and have minimal side effects.
Opportunities for introducing new products, services, and devices are high as the market consists of established players and their brands. However, the market is still in search of highly efficient products and portable and technologically advanced devices. Safety and efficacy are major concerns in the pigmentation disorders treatment market. Therefore, introduction of such products presents a window of opportunity for new players to enter the market and establish themselves. The appreciation of regulatory compliance is a major factor that contributes to the success or failure of treatments, thus affecting sales. Galderma launched the triple combination to improve compliance of its key product, Tri-luma. Increased patient and provider awareness is also likely to help increase patient share of many marketed therapies during the forecast period.
Red Biotechnology Market: Business Overview and Global Development Trends
Red Biotechnology Market: Business Overview and Global Development Trends
The new study by TMR reveals key insights into the red biotechnology landscape, allowing report audiences to gain a holistic market overview. According to this TMR study, sales revenues from the red biotechnology market valued at US$ 314.2 billion in 2018. The increasing prevalence of chronic diseases, rapid expansion of the biopharmaceutical industry, and increased global expenditure on the healthcare industry are likely to uphold the growth of the red biotechnology market. Moreover, the growing awareness of chronic disease treatment and robust pipeline of new therapeutic molecules are expected to drive the global red biotechnology market.
Planning to lay down future strategy? Perfect your plan with our report brochure here
Life Science Reagents Market Trends and Growth Factors Analysis
Life Science Reagents Market Trends and Growth Factors Analysis
Life Science Reagent – Key Instrument to Increase Life Expectancy
Driven by the shifting paradigms of patients from 'treatment' to 'wellness', the healthcare industry has been advancing with significant breakthroughs in recent times. As 'early diagnosis' becomes the new norm in the healthcare industry, the development of effective cures becomes extremely important to beat the increasing rate of viral epidemics, their sequelae, and improve the mortality rate of patients.
Considering this trend, life science reagent manufacturers are vying to develop analytical instruments that decrease the diagnostic time and support the early-stage analysis of varied disorders. With patients having the leeway to choose their preferred diagnostic centers, point-of-care diagnostic centers such as clinics or homes are found to exceed laboratory-based diagnostics. Transparency Market Research (TMR), in its recent study, assesses the life science reagents market at a microscopic level, to acquire distinguished insights as to how the growth of the market is expected to unfold in the future, and offer actionable intelligence to the readers.
Planning to lay down future strategy? Perfect your plan with our report brochure here
Gemcitabine HCL Market - Major Factors Driving the Industry
Gemcitabine HCL Market - Major Factors Driving the Industry
Gemcitabine HCl: A Novel Anti-Cancer Drug
The global healthcare space has made phenomenal strides over the years, and cultural shifts, policy adjustments, and cost of care have contributed to a more patient-empowered shift in care delivery systems. As cancer is becoming one of the most expensive diseases to treat, the implementation of clinical pathways in oncology is gaining its very own eminence, which serves as an important tool in reducing variability in care delivery, improving outcomes, and controlling costs.
As several chemotherapy compounds have demonstrated activity against human malignancies, and fillings for Abbreviated New Drug Application (ANDA) have increased, the gemcitabine HCl market necessitates a thorough understanding and unbiased analysis. Transparency Market Research (TMR), in its new research study, brings to fore compelling insights and dynamic analysis to help its readers gain an in-depth understanding of the gemcitabine HCl market behavior in 2019 and beyond.
Identify the key factors that will drive your company’s growth. Request a brochure of this report here
Postoperative Pain Therapeutics Market - Brief Analysis by Top Key Players
Postoperative Pain Therapeutics Market - Brief Analysis by Top Key Players
Rising geriatric population and increasing incidence of surgical procedure are major factors driving demand for postoperative pain therapeutics. Chronic postoperative pain associated with surgical procedures continues for longer duration. Usually, it persists for three to six months. Postoperative pain after amputation of limb, cesarean section, thoracotomy, breast surgery, or inguinal hernia repair is named as phantom pain.
As per reports published by reputed medical institutes, postoperative pain is not well-managed in approximately one-third of the patients.
However, rising awareness regarding severity of postoperative pain and increasing number of surgical procedures are likely to fuel postoperative pain therapeutics market in forthcoming years.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67271
Opioid Tolerance Treatment Market Development, Trends, Segmentations Analysis
Opioid Tolerance Treatment Market Development, Trends, Segmentations Analysis
Global Opioid Tolerance Treatment – Overview:
Opioid treatment is massively noted in severe pain management and chronic cancer treatment. One of the reasons behind their extensive use is high efficacy. However, there are negative implication sometimes noted when these are used for a longer time. The effect in therapy reduces, and response to therapy becomes dull. Such patients require either higher doses or NMDA antagonists. Alpha2-adrenoceptor agonists are also put to work sometimes.
As per a comprehensive analysis by Transparency Market Research, the market for opioid tolerance treatment will record moderate growth in the market, expanding the opportunities landscape for market players. Valuation of the market would also see growth in the period 2019 to 2027 – the assessment period of the growth.
Some of the prominent factors leading to growth in the market are outlined below. These are molding the future of the market in a major way.
- Drug abuse is gaining a firm foothold across countries and communities. Some of the regions that are facing a menace in terms of opium use are the countries falling in proximity to the Golden Crescent and the Golden Triangle – regions known for illicit opium production in the Asia Pacific region. Authorities and medical community is trying to fight this through research and development, and development of better therapeutics, paving way for growth in the market.
- A robust pipeline exists in the market for tolerance treatment and a number of clinical trials are underway. This ensures growth for the global opioid tolerance treatment market over the forecast period. The use in healthcare will be a major factor of growth.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66896
Gout Therapeutic Market Segments, Leading Player, Application & Forecast Analysi
Gout Therapeutic Market Segments, Leading Player, Application & Forecast Analysi
High growth rate of the gout therapeutics market is attributed because of following factors
- Increase in drug pipeline
- Easy availability,
- Rise in the demand for biologics for treatment of gout across the globe.
Gout is a type of inflammatory arthritis caused by small crystals of a chemical called uric acid that form in the joints. If uric acid levels in the blood remain elevated, thin rod-like crystals can form and deposit in the joints, which can lead to severe pain, tenderness, stiffness, swelling, and joint damage.
Gout has both active and inactive periods. Active periods of gout are known as ‘attacks’ and can vary in severity and length. Diagnosis of gout is confirmed by synovial fluid analysis. Incidence of gout has been rising consistently over the last few years.
- According to Nationwide Emergency Department Sample (NEDS), total number of ED visits per year among patients with a primary diagnosis of acute gout increased 26.8% between 2006 and 2014; from 168,580 to 213,780.
Traditional therapies are witnessing a shift toward biologics. Rise in demand for effective treatment and new therapeutics launches are projected to propel the global gout therapeutics market during the forecast period. Efforts are being taken in various countries to spread awareness about chronic diseases and role of biologics in treating gout among the general population.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66875
Critical Limb Ischemia Treatment Market Key Players, Industry Overview and Forec
Critical Limb Ischemia Treatment Market Key Players, Industry Overview and Forec
Global Critical Limb Ischemia Treatment Market - Snapshot
The global critical limb ischemia treatment market is driven by rise in prevalence of critical limb ischemia. Growth of the market is also attributed to increase in awareness about critical limb ischemia and rich product pipeline.
Critical limb ischemia (CLI) is a severe peripheral arterial disease (PAD), wherein chronic inflammation associated with atherosclerosis (progressive thickening of arteries lining) causes reduced blood flow to the extremities (legs, feet, and hands), leading to severe pain and ulcers or sore. Major risk factors for critical limb ischemia comprise aging (people aged 60 or over are at high risk of developing this diseased condition), obesity, diabetes, high cholesterol level, smoking, sedentary lifestyle, and high blood pressure. Critical limb ischemia is associated with symptoms such as ischemic rest pain, gangrene, or tissue loss. Rise in prevalence of critical limb ischemia is anticipated to increase demand for therapeutics, which in turn is expected to drive the global critical limb ischemia treatment market. According to recent study, around 2 million to 3 million people suffer from critical limb ischemia in the U.S. Moreover, increase in health care expenditure and rise in the number of clinical trials are likely to propel the global critical limb ischemia treatment market.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2770
Epilepsy Therapeutics Market - SWOT Analysis of Major Industry Segments
Epilepsy Therapeutics Market - SWOT Analysis of Major Industry Segments
Epilepsy Therapeutics Market - SWOT Analysis of Major Industry Segments
Posted by monali on April 27th, 2020
The demand within the global epilepsy therapeutics market is slated to increase as new opportunities for medical analysis come to the fore of the medical industry. Neurological disorders have become a matter of concern for medical researchers who are looking at optimizing medical treatments. The stellar relevance of studying the neurological responses of the human body has created new opportunities for market maturity. In addition to this, the high incidence of neurological disorders amongst the geriatric population shall also aid market growth. As a distinct factor, epilepsy can affect the younger population groups as well. Therefore, the high vulnerability of people of all groups to epilepsy has created new avenues for market growth and revenues generation.
- Recurrent seizures can be a major problem for younger people with work and life commitments. Therefore, it is important to administer epilepsy treatments to ensure seamless functions of young individuals. Epilepsy is a severe disorder that can hamper normal functioning of individuals, and can be a means to cause complete seizure of activity in affected individuals. The total volume of revenues within the global epilepsy therapeutics market is projected to touch new heights in the times to follow. The rising cases of head injuries, especially amongst sportspersons and athletes, has given an impetus to market growth and maturity.
- Genetic studies have led to improvements in epilepsy therapeutics, and this is an important dynamic of market growth. As new value propositions for epilepsy therapeutics come to the fore in recent times, the revenue index of the market shall improve. Neurologists are focusing on decoding the core reasons responsible for the occurrence of epilepsy. This factor has led to increased investments in medical research and development in recent times. Rising incidence of brain tumours has also generated a plethora of opportunities for growth within the market.
- Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2448
Cardiac Arrest Treatment Market: Pin-Point Analysis for Changing Competitive Dyn
Cardiac Arrest Treatment Market: Pin-Point Analysis for Changing Competitive Dyn
Global Cardiac Arrest Treatment Market – An Overview
World over cardiovascular diseases are seeing an increase in incidence. Additionally, certain underlying issues such as agonal breathing or apnea, which are known to cause cardiac arrest, are seeing an increase in numbers of people affected. Some of the reasons include lifestyle choices – alcohol and tobacco use, lack of exercise and a hectic work schedule.
As per Transparency Market Research, this will lead to growth in the global cardiac arrest treatment market over the forecast period of 2019 to 2020. A number of factors would underlie this growth and lead to generation of lucrative growth opportunities. Besides, they will pull up the market worth by a considerable value.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=61416
To understand what is driving the market forward, it is significant to note the following:
- World over, geriatric population is seeing an increase in numbers. The year 2018 saw history being created with number of people in the geriatric bracket of 65 and above crossed number of children. The age bracket of the latter is below 6. By the year 2050, numbers will grow further in the former. Worldwide, one in every six and in North America and Europe, one in every four people will fall in the age group of 65 and above. This age group is susceptible to cardiac arrest.
- Risk of CVD increases with certain diseases such as diabetes and conditions such as hypertension, hyperlipidaemia, and others. And, it is pertinent to note here that an increase in incidence of these will lead to a high risk for CVD, paving way for growth in the global cardiac arrest treatment market over the forecast period. Note that the number one cause of deaths in the world is CVD.
Equine Supplement Products Market: Technological Growth Map with an Impact-Analy
Equine Supplement Products Market: Technological Growth Map with an Impact-Analy
Global Equine Supplement Products Market - Snapshot
The global equine supplement products market is driven by rise in demand for herbal equine supplements, increase in incidence of equine diseases, and surge in government initiatives toward equine health. Moreover, increase in demand for equine feeds to boost performance and new product launches by players are likely to boost the growth of the market during the forecast period. For instance, in December 2018, Hagyard Pharmacy launched REVYVE, a pre- and probiotic to maintain gastrointestinal (GI) health, expanding its product portfolio for equine health. In June 2017, Purina Animal Nutrition LLC. launched horse feed product line including Outlast Gastric Support Supplement, Race Ready GT, and Ultium Gastric Care to expand its product portfolio for gastrointestinal health of horses. Additionally, strategic partnerships, acquisitions, and mergers by market players in the past few years are likely to boost the growth of the market during the forecast period. In December 2017, Pyranha acquired Adeptus Nutrition, a company offering equine nutrition supplements, to address the need of supplement products by animal owners.
Based on supplement, the global equine supplement products market has been segmented into proteins/amino acids, vitamins, enzymes, electrolytes/minerals, and others. The electrolytes/minerals segment is projected to account for major share of the market during the forecast period, attributed to increase in the availability of electrolyte supplements in the market and rise in awareness about deficiency of mineral nutrients in horses. In terms of application, the market has been classified into performance enhancement/recovery, join disorder prevention, and others. The join disorder prevention segment held the largest market share in 2018. The growth of the segment is attributed to rise in awareness among horse owners to reduce lameness associated with osteoarthritis. Based on distribution channel, the global equine supplement supplements market has been categorized into veterinary hospital pharmacies, retail pharmacies, and others. The veterinary hospital pharmacies segment is expected to expand at the fastest CAGR due to rise in owner preference to get horses treated in hospitals and increase availability of veterinary supplements in hospital pharmacies.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66551
Friday, April 24, 2020
Ventilators Market - Share Projected to Garner Significant Revenues by 2027
Ventilators Market - Share Projected to Garner Significant Revenues by 2027
Global Ventilators Market: Overview
Multiple factors are leading to increase in demand for ventilators. Some of the include increased focus on intensive care and rapidly rising population of geriatric population worldwide. To compound the situation further is increase in chronic diseases. As the world sees failing health owing to lifestyle changes and demographics shift, market for ventilators chart an upward growth.
Therefore, it is easy to see why the global market for ventilators is expected to grow at an impressive CAGR (Compound Annual Growth Rate), translating to a good generation of market opportunities over the forecast period of 2019-2027.
Global Ventilators Market: Competitive Landscape
The global ventilators market is undergoing critical developments in its landscape. It is setting the tone for future competition as well as paving the road to growth over the forecast period.
The global ventilators market is slightly fragmented and key players in the market landscape include Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand). In order to maintain competitive edge, players enter strategic collaborations work towards product development.
Get an Idea about the Offerings of Our Ventilators Market Report from this Brochure
Surgical Mask Market Forecast: Technological Growth Map with an Impact-Analysis
Surgical Mask Market Forecast: Technological Growth Map with an Impact-Analysis
Global Surgical Mask Market: Overview
The demand within the global market for surgical mask has been rising on account of advancements in the field of medical surgery and diagnosis. Surgical masks are meant to protect doctors and surgeons from harmful infections and pathogens that may get suspended in the surgery room. Furthermore, the patient who is under treatment also needs to be protected from infectious agents that may be discharged by others in the surgery rooms. Hence, the global market for surgical mask is expected to expand at a stellar pace in the years to follow. There have been multiple attempts at manufacturing improved surgical masks, and this has given an impetus to market growth.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67823
The presence of a seamless healthcare sector, coupled with utmost focus on safer surgical procedures, has given an impetus to the growth of the global surgical mask market. Furthermore, the need maintaining quality standards across the healthcare domain has also built a plethora of opportunities across the globe. Hence, the global market for surgical mask is projected to win voluminous revenues in the years to come. The efforts of medical facilities in equipping medical practitioners and surgeons with the best surgical masks have aided market growth.
The global market for surgical mask can be segmented on the basis of the following parameters: product, distribution channel, and region. On the basis product, the global surgical mask can be segmented into anti-fog surgical mask, basic surgical mask, fluid/splash resistant surgical mask, N95 mask, and others. Amongst these, the market for basic surgical mask has flown in from multiple healthcare facilities. The key distribution channels for surgical masks are drug stores, hospitals and clinics, and online stores.
Facial Mask Market Share Insight on the Important Factors and Trends Influencing
Facial Mask Market Share Insight on the Important Factors and Trends Influencing
Facial masks are seamless skin care therapy or treatment for different skin concerns. The use of an appropriate facial mask can help remove excess oil, hydrate the skin, improve the appearance of pores on the face, and also help pull out impurities. Healthy skin care treatment incorporates daily use and weekly use of skin care products. Facial mask can be used once a week or more depending on the skin and related skin care concerns. Facial mask can be used by both women and men. Appling a facial mask has several other benefits such as it provides relaxation, deep cleaning, unclogs pores, and imparts glowing skin.
The global facial mask market is driven by various factors such as increasing availability of customized products, their ease of use, lifestyle changes, and growing number of beauty shops which are estimated to increase the demand for facial masks during the forecast period. Facial mask is the simplest way to get healthier skin in a few minutes. Furthermore, the benefits advised by the new product which includes advanced treatment solution and it is also available for different skin type which are the key drivers that are estimated to grow the overall facial mask market in the near future. However, health issues are projected to hinder the facial mask market during the forecast period. Increasing penetration of new players in the market provides an opportunity to drive the facial mask market during the forecast period.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=38546
The global facial mask market has been segmented in terms of packaging, mask type, distribution channel, end-user, and region. In terms of type of packaging, the market has been divided into tubes, sachets, jar, and containers. Based on mask type, the market can be segmented into natural ingredient mask, clay mask, peel off mask, warm oil mask, cream mask, and self or thermal heating mask. Based on distribution channel, the market is bifurcated into online and offline. Online distribution channel comprises company websites and e-tailer websites. Offline distribution channel includes retail store, hyper market, super market, specialty stores, drug and pharmacy stores, direct selling, and others. The end-user segment is further segregated into general consumer use, salon, spa, beauty clinic, and others.
In terms of geography, the facial mask market is divided into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South America. The market in Asia Pacific is projected to grow the fastest during the forecast period as compared to other regions. This is mainly due to increasing facial mask brands in China from the past few years which is predicted to grow in the coming years.
Subscribe to:
Posts (Atom)